Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Grand Pharmaceutical Group Limited ( (HK:0512) ) has issued an update.
Grand Pharmaceutical Group Limited announced a Business Collaboration Agreement between its subsidiary Chengdu Shetai and Sirtex Medical US. This agreement allows both parties to engage each other for services related to research and development of medical device and radiopharmaceutical products, with a financial cap of US$1.2 million annually. The collaboration is expected to enhance the company’s capabilities in clinical development and logistics support, potentially strengthening its position in the medical industry.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company involved in the medical industry, focusing on the research and development of medical device products and radiopharmaceutical products. The company collaborates with various partners to enhance its offerings in treatment methods for human diseases.
YTD Price Performance: 29.63%
Average Trading Volume: 9,231,823
Technical Sentiment Signal: Sell
Current Market Cap: HK$21.12B
See more data about 0512 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue